CARE-HF LTFU: CArdiac REsynchronization in Heart Failure Long-Term Follow-up
This trial is active, not recruiting.
|Treatment||medtronic crt insync® family devices|
|Sponsor||Medtronic Bakken Research Center|
|Start date||September 2006|
|End date||July 2010|
|Trial size||550 participants|
|Trial identifier||NCT00318357, CARE-HF Long-term follow-up|
The CARE-HF long-term follow-up trial evaluates the effects of cardiac resynchronization (CR) therapy on the mortality of patients from the CARE-HF program for an additional 4 year follow-up. Investigators are free to choose whatever available treatment they believe is in the patient's best interest.
All cause Mortality
time frame: 4-year
Male or female participants at least 18 years old.
Inclusion Criteria: - Patients who have participated in the CARE-HF program and were reported to be alive in May 2005 - Patients who signed a patient data release consent form Exclusion Criteria: - Patients who have not participated in the CARE-HF program - Patients with exclusion criteria required by local legislation
|Official title||CARE-HF LTFU: CArdiac REsynchronization in Heart Failure Long-Term Follow-up|
|Description||The CARE-HF study enrolled 813 patients from 82 centers in 12 European countries (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, and UK). All patients that were reported to be alive in May 2005 will be asked to participate.|
Call for more information